May 2023. Thirty years after Biotechnica, a lighthouse fair for the European biotech industries, Deutsche Messe (DMAG) substituted the show by Labvolution. B2Bioworld asked Jochen Köckler, CEO of DMAG about the reasons to be content with much less exhibitors, less rented space, less visitors, less international attendance. What is the strategy behind the decisions, what will be implemented, and what are the prospects.Reading time: 11 min
Read Now: |
B2Bioworld offers you background information
A major exhibitor weighs Pros and Cons of reaching target groups with two major national trade fairs within one year
Jochen Köckler of Deutsche Messe AG about strategy after losses and global business
Andreas Gruchow, at the time President of UFI on practical do’s, challenges, and strategy
Schüler’s Compendium on German biotech industry - open access
Neuroscience researcher Tom Baden creates his own tools, and pioneers visual information processing
The CEO of Köttermann with insights on manufacturers, architects, lab planners, and competitors from IKEA to do-it-yourself. Complemented with data on U.S. laboratory market and Domains of Japan's Analytical Instrument Manufacturers